vadimezan has been researched along with okadaic acid in 1 studies
Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (okadaic acid) | Trials (okadaic acid) | Recent Studies (post-2010) (okadaic acid) |
---|---|---|---|---|---|
272 | 16 | 101 | 3,865 | 2 | 658 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baguley, BC; Ching, LM; Philpott, M | 1 |
1 other study(ies) available for vadimezan and okadaic acid
Article | Year |
---|---|
The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor.
Topics: Antineoplastic Agents; Cell Culture Techniques; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Lipopolysaccharides; NF-kappa B; Okadaic Acid; Salicylic Acid; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 2001 |